FilingSEC EDGAR8-K
Annovis Bio Receives NYSE Non-Compliance Notice
· SEC accepted
StageListing Warning
Filing content
Annovis Bio received a notice from the NYSE regarding non-compliance with continued listing standards due to market capitalization and stockholders' equity falling below $50 million.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…